Evidence for the differential expression of a variant EGF receptor protein in human prostate cancer

British Journal of Cancer

Volumn 82, Issue 1, 2000, Pages 186-194

  Olapade Olaopa, E O ^a,d   Moscatello, D K ^b   MacKay, E H ^a   Horsburgh, T ^a   Sandhu, D P S ^a   Terry, T R ^a   Wong, A J ^b   Habib, F K ^c  

^a LEICESTER GENERAL HOSPITAL   (United Kingdom)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c WESTERN GENERAL HOSPITAL   (United Kingdom)

^d UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

EGFR; Hormone resistance; Prostate prognostic factors; Stromal epithelial interaction; Tumour marker

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; MESSENGER RNA; TUMOR MARKER;

ANTIBODY SPECIFICITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; MALE; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 1842626080     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.1999.0898     Document Type: Article

References (47)

1. Barlett J, Langdon S, Simpson B, Stewart M, Katsaros D, Simondi P, Love S, Scott W, Williams A, Lessells A, Macleod K, Smyth J and Miller W (1996) The prognostic value of epidermal growth factor receptor mRNA expression in primary ovarian cancer. Br J Cancer 73: 301-306
2. Bostwick D, Pacelli A, Blute M, Roche P and Murphy G (1998) Prostate specific membrane antigen expression in prostalic intraepithelial neoplasia and adenocarcinoma: a study of 184 cases. Cancer 82: 2256-2261
3. Cohen D, Simark R, Fair W, Melamed J, Scher H and Cordon-Cardo C (1994) Expression of transforming growth factor-alpha and the epidermal growth factor receptor in human prostatic tissue. J Urol 152: 2120-2124
4. Cross M and Dexter T (1991) Growth factors in development, transformation and tumorigenesis (review). Cell 64: 271-280
5. Davies P, Eaton C, France T and Philips E (1988) Growth factor receptors and oncogene expression in prostatic cell. Am J Clin Oncol Supplement 2: S1-S7
6. Derynck R, Goeddel D, Ulrich A, Gutterman J, Williams R, Bringman T and Berger W (1993) Synthesis of messenger RNAs for transforming growth factors alpha and beta and the epidermal growth receptor by human tumours. Cancer Res 47: 707-712
7. Ekstrand A, Sugawa N, James C and Collins V (1992) Amplified and rearranged epidermal growth factor genes in human glioblaslomas reveal deletion sequences encoding portions of the N-and/or C-terminal tails. Proc Natl Acad Sci USA 89: 4309-4313
8. Fong C, Sherwood E, Mendelsohn J, Lee C and Kozlowski J (1992) Epidermal growth facor receptor monoclonal antibody inhibits constitutive receptor phosphorylation, reduces autonomous growth, and sensitizes androgen-independent prostatic carcinoma cells to tumour necrosis factor alpha. Cancer Res 52: 5887-5892
9. Gleason D, Mellinger G and Group, TVACUR (1974) Prediction of prognosis for prostate adenocarcinoma by combined histological grading and clinical staging. J Urol 111: 58-64
10. Glynne-Jones E, Goddard L and Harper M (1996) Comparative analysis of mRNA and protein expression for EGFR and ligands: relationship to proliferative index of human prostate tissue. Hum Pathol 27: 688-696
11. Greig R, Dunnington D, Murthy U and Marin A (1988) Growth factors as novel therapeutic targets in neoplastic disease. Cancer Surv 7; 644-674
12. Gullick W (1998) Type 1 growth factor receptors: current status and future work. Biochem Soc Symp 63: 193-198
13. Haggman M, Macoska J, Wonjo K and Oesterling J (1997) The relationship between prostatic intraepithelial neoplasia and prostate cancer. J Urol 158: 12-22
14. Humphrey P, Wong A, Vogelstein B, Zalutsky M. Fuller G, Archer G, Friedman H, Kwatra M, Bigner S and Bigner D (1990) Anti-synthetic peptide antibody reacting at the fusion junction of deletion-mutant epidermal growth factor receptor in human glioblastoma. Proc Natl Acad Sci USA 87: 4207-4211
15. Hunts J, Ueda M, Ozawa S, Abe O, Pastan I and Shimuzi N (1985) Hyperproduction and gene amplification of the epidermal growth factor receptor in squamous cell carcinomas. Jpn J Cancer Res 76: 663-666
16. Kristt D and Yarden Y (1996) Differences between phosphotyrosine accumulation and Neu/Erb-2 receptor expression in astrocytic proliferative processes. Cancer 78: 1272-1283
17. Laemmli U (1970) Cleavage of structural proteins during the assembly of head haeteriophage. Nature 227: 680-685
18. Maddy S, Chisholm G, Hawkins R and Habib F (1987) Localisation of epidermal growth factor receptors in the human prostate by biochemical and immunocytochemical methods. J Endocrinol 113: 147-153
19. Maddy S, Chisholm G, Busuttil A and Habib F (1989) Epidermal growth factor receptors in prostate cancer; correlation with histological differentiation of the tumour. Br J Cancer 60: 41-44
20. Maygarden S, Strom S and Ware J (1992) Localisation of epidermal growth factor receptor by immunohistochemical methods in human prostatic carcinoma, prostatic intraepithelial neoplasia, and benign hyperplasia. Arch Pathol Lab Med 116: 269-273
21. Mellon K, Thompson S, Charlton R, Marsh C, Robinson M, Lane D, Harris A, Horne C and Neal D (1992) p53, c-crbB-2 and the epidermal growth factor receptor in the benign and malignant prostate. J Urol 147: 496-499
22. Modjtahedi H, Hickish T, Nicolson M, Moore J, Styles J, Eccles S, Jackson F, Salter J, Sloane J, Spencer L, Priest K, Smith I, Dean C and Gore M (1996) Phase 1 trial and tumour localisation of the anti-EGFR monoclonal antibody in head and neck or lung cancer. Br J Cancer 73: 228-235
23. Morris G and Dodd J (1990) Epidermal growth receptor mRNA levels in human prostatic tumour cell lines. J Urology 143: 1272-1274
24. Moscatello K, Holga-Madruga M, Godwin A, Ramirez G, Gunn G, Zoltick P, Biegel J, Hayes R and Wong A (1995) Frequent expression of a mutant epidermal growth factor receptor in multiple human tumours. Cancer Res 55: 5536-5539
25. Moscatello D, Montgomery R, Sunderashan P, McDanel H, Wong M and Wong A (1996) Transformation and altered signal transduction by a naturally occurring mutant EGF receptor. Oncogene 13: 85-96
26. Moscatello D, Ramirez G and Wong A (1997) A naturally occurring mutant human epidermal growth factor as a target for peptide vaccine immunotherapy of tumours. Cancer Res 57: 1419-1424
27. Nagane M, Coufal F, Lin H, Bogler O, Cavenee W and Huang SH-J (1996) A common mutant epidermal growth factor receptor confers enhanced tumorigenicity on human glioblastoma cells by increasing proliferation and reducing apoptosis. Cancer Res 56: 5079-5086
28. Newby J, Johnston S, Smith I and Dowsett M (1997) Expression of epidermal growth factor receptor and c-erbB2 during the development of tamoxifen resistance in human breast cancer. Clin Cancer Res 3: 1643-1651
29. Nishakawa R, Ji X-D, Harmon R, Lazar C, Gill G, Cavenee W and Huang H-J (1994) A mutant epidermal growth factor receptor common in human gliomas confers enhanced tumorigencity. Proc Natl Acad Sci USA 91: 7727-7731
30. Olapade-Olaopa E, MacKay E and Habib F (1998) Variability of immunohistochemical reactivity on stored paraffin slides (letter). J Clin Pathol 51; 943
31. Olapade-Olaopa E, MacKay H, Taub N, Sandhu D, Terry T and Habib F (1999) Malignant transformation of human prostatic epithelium is associated with the loss of androgen receptor immuno-reactivity in surrounding stroma. Clin Cancer Res 5; 569-576
32. Ozanne B, Richards C, Hendler F, Burns D and Gusterson B (1986) Overexpression of the HGF receptor is a hallmark of squamous cell carcinoma. J Pathol 149: 9-14
33. Panneerselvam K, Kanakaj P. Raj S, Das M and Bishayee S (1995) Characterisation of a novel epidermal-growth-factor-related 200-kDa tyrosine kinase in tumour cells. Eur J Biochem 230: 951-957
34. Putz T, Culig 7., Eder I, Nessler-Menardi C, Bartsch G, Grunike H. Uberall F and Klocker H (1999) Epidermal growth factor (EGF) receptor blockade inhibits the action of EGF, insulin-like growth factor I, and a protein kinase A activator on the mitogen-activated protein kinase pathway in prostate cancer cell lines. Cancer Res 59: 227-233
35. Ro J, North S, Gallick G, Hortobagyi G, Gutterman J and Blick M (1988) Amplified and overexpressed epidermal growth factor receptor gene in uncultured primary human breast carcinoma. Cancer Res 48: 161-364
36. Sainsbury J, Farndon J, Needham G. Malcom A and Harris A (1987) Epidermal growth factor receptor status as predictor of early recurrence and death from breast cancer. Lancet 1: 1398-1402
37. Sakr W and Grigon D (1997) Prostate cancer: indicators of aggressiveness. Eur Urol 32: 15-23
38. Schmidt M, Reisser P, Hills D, Gullick W and Wels W (1998) Expression of an oncogenic mutant EGF receptor markedly increases the sensitivity of cells to an EGF-receptor-specific antibody-toxin. Int J Cancer 75: 878-884
39. Sherwood E, Dongen JV, Wood C, Eiao S, Kozlowski J and Lee C (1998) Epidermal growth factor receptor activation in androgen-independent but not androgen-stimulated growth of human prostatic carcinoma cells. Br J Cancer 77: 855-861
40. Thompson D and Gill G (1985) The EGF receplor: structure, regulation and potential role in malignancy. Cancer Surv 4. 767-788
41. Tukeri L, Sakr W, Wykes S, Grigon D, Puntes J and Macoska J (1994) Comparative analysis of epidermal growth factor receptor gene expression and protein product in benign and malignant prostate tissue. Prostate 25: 199-205
42. Ulrich A, Coussens E, Hayflick J, Dull T, Gray A, Tam A, Lee J, Yarden Y, Libermann T, Schlessinger J, Downward J, Maves E, Whittle N, Waterfield M and Seeberg P (1984) Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature (London) 309: 418-425
43. Wikstrand C, Hale L, Batra S, Hill M, Humphrey P, Kurpad S, McLendon R, Moscatello D, Pegram C, Reist C, Traweek S, Wong A, Zalutsky M and Bigner D (1995) Monoclonal antibodies against EGFRv III are tumor specific and react with breast and lung carcinomas and malignant gliomas. Cancer Res 55: 3140-3148
44. Wong A, Bigner S, Bigner D, Kinzler K, Hamilton S and Vogelstein B (1987) Increased expression of the EGF receptor gene in malignant gliomas is invariably associated with gene amplification. Proc Natl Acad Sci USA 84: 6899-6903
45. Wong A, Ruppert J, Bigner S, Grzechick C, Humphrey P, Bigner D and Volgstein B (1990) Structural alterations of the epidermal growth factor receptor gene in human gliomas. Proc Natl Acad Sci USA 87: 4207-4211
46. Wong A, Ruppert J, Bigner S, Grzeschik C, Humphrey P. Bigner D and Vogelstein B (1992) Structural alterations of the epidermal growth factor receptor gene in human gliomas. Proc Natl Acad Sci USA 89: 2965-2969
47. Xu Y, Richert N, Ito S, Merlino G and Pastan I (1984) Characterisation of epidermal growth factor receptor gene expression in malignant and normal human cell lines. Proc Natl Arcad Sci USA, 81: 7308-7312